|
|
Vaccine Detail
|
Carcinoembryonic Antigen Peptide 1-6D Virus-Like Replicon Particles Vaccine |
| Vaccine Information |
- Vaccine Name: Carcinoembryonic Antigen Peptide 1-6D Virus-Like Replicon Particles Vaccine
- Target Pathogen: Cancer
- Target Disease: Cancer
- Vaccine Ontology ID: VO_0007352
- Type: Other
- Status: Clinical trial
- Host Species for Licensed Use: Human
- Host Species as Laboratory Animal Model: Human
- CEACAM5 (CEA)
gene engineering:
- Type: Recombinant protein preparation
- Description:
- Detailed Gene Information: Click Here.
- Description: A cancer vaccine, consisting of alphavirus vector-derived virus-like replicon particles expressing the 9-amino-acid carcinoembryonic antigen peptide (CAP) 1-6D, with potential antineoplastic activity. Vaccination with this agent may elicit a cytotoxic T lymphocyte (CTL) immune response against CEA-expressing tumor cells. (NCIT_C70644).
|
| Host Response |
|
|
| References |
NCIT_C70644: [https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C70644]
|
|
